Response to 'Correspondence on "Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence" by Zhang et al

Ann Rheum Dis. 2022 Dec;81(12):e253. doi: 10.1136/annrheumdis-2020-218944. Epub 2020 Oct 1.
No abstract available

Keywords: ankylosing; osteoporosis; spondylitis; tumor necrosis factor inhibitors.

Publication types

  • Comment

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Humans
  • Spondylitis, Ankylosing* / diagnostic imaging
  • Spondylitis, Ankylosing* / drug therapy
  • Spondylitis, Ankylosing* / pathology
  • Tumor Necrosis Factor Inhibitors / therapeutic use
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor Inhibitors
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha